# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001599298-22-000147
Filing Date
2022-12-21
Accepted
2022-12-21 16:20:10
Documents
99
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K/A | smmt-20211231.htm iXBRL | 10-K/A | 1212733
2 | EX-23.1 | sum-ex231_20211231x10xkaxu.htm | EX-23.1 | 2304
3 | EX-23.2 | sum-ex232_20211231x10xkaxu.htm | EX-23.2 | 2354
4 | EX-31.1 | sum-ex311_20211231x10xka.htm | EX-31.1 | 11766
5 | EX-31.2 | sum-ex312_20211231x10xka.htm | EX-31.2 | 11791
6 | EX-31.3 | sum-ex313_20211231x10xka.htm | EX-31.3 | 11745
7 | EX-32.1 | sum-ex321_20211231x10xka.htm | EX-32.1 | 11053
| Complete submission text file | 0001599298-22-000147.txt |  | 7676003

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | smmt-20211231.xsd | EX-101.SCH | 61638
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | smmt-20211231_cal.xml | EX-101.CAL | 82949
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | smmt-20211231_def.xml | EX-101.DEF | 257384
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | smmt-20211231_lab.xml | EX-101.LAB | 724092
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | smmt-20211231_pre.xml | EX-101.PRE | 507240
93 | EXTRACTED XBRL INSTANCE DOCUMENT | smmt-20211231_htm.xml | XML | 1168125

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36866 | Film No.: 221478672
SIC: 2834 Pharmaceutical Preparations